Neurocognitive Remediation clinical trials

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

This study looks at new ways to treat medulloblastoma, a type of brain cancer, in children and young adults. It uses a personalised approach, tailoring treatment based on individual tumour features, aiming for better results with fewer side effects.